Compound heterozygous SLC19A3 mutations further refine the critical promoter region for biotin-thiamine-responsive basal ganglia disease
暂无分享,去创建一个
Whitney Whitford | Klaus Lehnert | Russell G. Snell | Jessie C. Jacobsen | Donald R. Love | Rosamund Hill | J. C. Jacobsen | R. Snell | E. Glamuzina | D. Love | W. Whitford | K. Lehnert | Fern Ashton | Rosamund Hill | Isobel Hawkins | Emma Glamuzina | Francessa Wilson | Andrew Marshall | Juliet Taylor | Juliet Taylor | A. Marshall | F. Ashton | Isobel Hawkins | Francessa Wilson
[1] Toshihiro Tanaka. The International HapMap Project , 2003, Nature.
[2] A. Hazell,et al. Modeling neurodegenerative disease pathophysiology in thiamine deficiency: Consequences of impaired oxidative metabolism , 2011, Neurochemistry International.
[3] S. Khan,et al. Biotin-responsive basal ganglia disease revisited , 2013, Neurology.
[4] N. Vaziri,et al. Thiamin uptake by the human-derived renal epithelial (HEK-293) cells: cellular and molecular mechanisms. , 2006, American journal of physiology. Renal physiology.
[5] G. Gascon,et al. Biotin-responsive basal ganglia disease: a novel entity. , 1998, Brain : a journal of neurology.
[6] Da-Neng Wang,et al. Structure and Mechanism of the Glycerol-3-Phosphate Transporter from Escherichia coli , 2003, Science.
[7] M. Alfadhel,et al. Treatment of biotin-responsive basal ganglia disease: Open comparative study between the combination of biotin plus thiamine versus thiamine alone. , 2015, European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society.
[8] J. Zempleni,et al. The nuclear abundance of transcription factors Sp1 and Sp3 depends on biotin in Jurkat cells. , 2003, The Journal of nutrition.
[9] David J. States,et al. Identification of protein coding regions by database similarity search , 1993, Nature Genetics.
[10] Richard Durbin,et al. Sequence analysis Fast and accurate short read alignment with Burrows – Wheeler transform , 2009 .
[11] A. Yamaguchi,et al. Complete Cysteine-scanning Mutagenesis and Site-directed Chemical Modification of the Tn10-encoded Metal-Tetracycline/H+ Antiporter* , 2001, The Journal of Biological Chemistry.
[12] Hitoshi Suzuki,et al. Mutations in a thiamine-transporter gene and Wernicke's-like encephalopathy. , 2009, The New England journal of medicine.
[13] H. Smeets,et al. Reply: Infantile Leigh-like syndrome caused by SLC19A3 mutations is a treatable disease. , 2014, Brain : a journal of neurology.
[14] T. I. Vlasova,et al. Biotin deficiency reduces expression of SLC19A3, a potential biotin transporter, in leukocytes from human blood. , 2005, The Journal of nutrition.
[15] M. Gerstein,et al. CNVnator: an approach to discover, genotype, and characterize typical and atypical CNVs from family and population genome sequencing. , 2011, Genome research.
[16] S. Rahman,et al. Treatable Leigh-like encephalopathy presenting in adolescence , 2013, BMJ Case Reports.
[17] J. Marchant,et al. Biotin-responsive basal ganglia disease-linked mutations inhibit thiamine transport via hTHTR2: biotin is not a substrate for hTHTR2. , 2006, American journal of physiology. Cell physiology.
[18] Ellen T. Gelfand,et al. The Genotype-Tissue Expression (GTEx) project , 2013, Nature Genetics.
[19] S. Iwata,et al. Structure and Mechanism of the Lactose Permease of Escherichia coli , 2003, Science.
[20] Fanfan Zhou,et al. The role of glycine residues in the function of human organic anion transporter 4. , 2004, Molecular pharmacology.
[21] I. Jonassen,et al. Novel SLC19A3 Promoter Deletion and Allelic Silencing in Biotin-Thiamine-Responsive Basal Ganglia Encephalopathy , 2016, PloS one.
[22] J. Abdenur,et al. Whole exome sequencing reveals compound heterozygous mutations in SLC19A3 causing biotin-thiamine responsive basal ganglia disease , 2014, Molecular genetics and metabolism reports.
[23] T. Gillis,et al. Biotin-responsive basal ganglia disease maps to 2q36.3 and is due to mutations in SLC19A3. , 2005, American journal of human genetics.
[24] M. Alfadhel,et al. Biotin-responsive basal ganglia disease should be renamed biotin-thiamine-responsive basal ganglia disease: a retrospective review of the clinical, radiological and molecular findings of 18 new cases , 2013, Orphanet Journal of Rare Diseases.
[25] Andrew J. Hill,et al. Analysis of protein-coding genetic variation in 60,706 humans , 2015, bioRxiv.
[26] H. Said,et al. In vitro and in vivo characterization of the minimal promoter region of the human thiamin transporter SLC19A2. , 2003, American journal of physiology. Cell physiology.
[27] B. Wlodarczyk,et al. Identification and characterization of the human and mouse SLC19A3 gene: a novel member of the reduced folate family of micronutrient transporter genes. , 2000, Molecular genetics and metabolism.
[28] Q. Waisfisz,et al. Exome sequencing reveals mutated SLC19A3 in patients withan early-infantile, lethal, encephalopathy , 2013, Brain : a journal of neurology.
[29] T. Acker,et al. Stress‐Induced Upregulation of SLC19A3 is Impaired in Biotin‐Thiamine‐Responsive Basal Ganglia Disease , 2014, Brain pathology.
[30] C. Richelme,et al. The severity of phenotype linked to SUCLG1 mutations could be correlated with residual amount of SUCLG1 protein , 2010, Journal of Medical Genetics.
[31] R. Artuch,et al. Reversible Lactic Acidosis in a Newborn With Thiamine Transporter-2 Deficiency , 2013, Pediatrics.
[32] H. Said,et al. Adaptive regulation of human intestinal thiamine uptake by extracellular substrate level: a role for THTR-2 transcriptional regulation. , 2013, American journal of physiology. Gastrointestinal and liver physiology.
[33] H. Said,et al. Characterization of the 5'-regulatory region of the human thiamin transporter SLC19A3: in vitro and in vivo studies. , 2004, American journal of physiology. Gastrointestinal and liver physiology.
[34] K. Amunts,et al. Biotin-responsive Basal Ganglia disease: a treatable differential diagnosis of leigh syndrome. , 2013, JIMD reports.
[35] C. Ferreira,et al. Biotin‐thiamine responsive basal ganglia disease: Identification of a pyruvate peak on brain spectroscopy, novel mutation in SLC19A3, and calculation of prevalence based on allele frequencies from aggregated next‐generation sequencing data , 2017, American journal of medical genetics. Part A.
[36] G. von Heijne,et al. Tissue-based map of the human proteome , 2015, Science.
[37] Nan Li,et al. Identification of Amino Acids Essential for Estrone-3-Sulfate Transport within Transmembrane Domain 2 of Organic Anion Transporting Polypeptide 1B1 , 2012, PloS one.
[38] N. Longo,et al. Glutaric acidemia type 1 , 2006, American journal of medical genetics. Part C, Seminars in medical genetics.
[39] Sriram Subramaniam,et al. Three-dimensional structure of a bacterial oxalate transporter , 2002, Nature Structural Biology.
[40] James Y. Zou. Analysis of protein-coding genetic variation in 60,706 humans , 2015, Nature.
[41] T. Meitinger,et al. Infantile Leigh-like syndrome caused by SLC19A3 mutations is a treatable disease. , 2014, Brain : a journal of neurology.
[42] R. Artuch,et al. Thiamine transporter-2 deficiency: outcome and treatment monitoring , 2014, Orphanet Journal of Rare Diseases.
[43] R. Płoski,et al. New perspective in diagnostics of mitochondrial disorders: two years’ experience with whole-exome sequencing at a national paediatric centre , 2016, Journal of Translational Medicine.
[44] P. Dudeja,et al. Expression and promoter analysis of SLC19A2 in the human intestine. , 2002, Biochimica et biophysica acta.
[45] A. Ribes,et al. Free-thiamine is a potential biomarker of thiamine transporter-2 deficiency: a treatable cause of Leigh syndrome. , 2016, Brain : a journal of neurology.
[46] J. Marchant,et al. Targeting and Trafficking of the Human Thiamine Transporter-2 in Epithelial Cells* , 2006, Journal of Biological Chemistry.
[47] M. DePristo,et al. A framework for variation discovery and genotyping using next-generation DNA sequencing data , 2011, Nature Genetics.
[48] R. Wibom,et al. Biotin and Thiamine Responsive Basal Ganglia Disease--A vital differential diagnosis in infants with severe encephalopathy. , 2016, European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society.
[49] H. Glaeser,et al. Relevance of conserved lysine and arginine residues in transmembrane helices for the transport activity of organic anion transporting polypeptide 1B3 , 2010, British journal of pharmacology.
[50] R. Wilson,et al. BreakDancer: An algorithm for high resolution mapping of genomic structural variation , 2009, Nature Methods.
[51] Christian H. Ahrens,et al. Protter: interactive protein feature visualization and integration with experimental proteomic data , 2014, Bioinform..
[52] N. Matsumoto,et al. Biotin-responsive basal ganglia disease: a case diagnosed by whole exome sequencing , 2015, Journal of Human Genetics.
[53] Gabor T. Marth,et al. A global reference for human genetic variation , 2015, Nature.
[54] Xiaolin Zhu,et al. An Evaluation of Copy Number Variation Detection Tools from Whole‐Exome Sequencing Data , 2014, Human mutation.
[55] J. Obeso,et al. Reversible generalized dystonia and encephalopathy from thiamine transporter 2 deficiency , 2012, Movement disorders : official journal of the Movement Disorder Society.
[56] Shane S. Sturrock,et al. Geneious Basic: An integrated and extendable desktop software platform for the organization and analysis of sequence data , 2012, Bioinform..
[57] H. Smeets,et al. Exome sequencing reveals a novel Moroccan founder mutation in SLC19A3 as a new cause of early-childhood fatal Leigh syndrome. , 2013, Brain : a journal of neurology.
[58] S. O. Smith,et al. Helix packing in polytopic membrane proteins: role of glycine in transmembrane helix association. , 1999, Biophysical journal.
[59] Helga Thorvaldsdóttir,et al. Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration , 2012, Briefings Bioinform..
[60] D. Galanaud,et al. Biotin-responsive basal ganglia disease in ethnic Europeans with novel SLC19A3 mutations. , 2010, Archives of neurology.
[61] H. Algahtani,et al. Biotin–thiamine–responsive basal ganglia disease: catastrophic consequences of delay in diagnosis and treatment , 2017, Neurological research.
[62] J. Marchant,et al. Expression and functional contribution of hTHTR-2 in thiamin absorption in human intestine. , 2004, American journal of physiology. Gastrointestinal and liver physiology.
[63] S. Tsuji,et al. A wide spectrum of clinical and brain MRI findings in patients with SLC19A3 mutations , 2010, BMC Medical Genetics.